Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 32026-05-14NCT06284317

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
AstraZeneca806
ETOP IBCSG Partners Foundation17

42 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alfred HospitalMelbourneAustralia3
Antwerp University HospitalAntwerpBelgium12
AOUS Policlinico Le ScotteSienaItaly2
Barts Health NHS TrustLondonUnited Kingdom30
Beaumont HospitalDublinIreland24
Chris O'Brien LifehouseCamperdownAustralia5
CHU AngersAngersFrance87
CHUVLausanneSwitzerland9
Eastern HealthBox HillAustralia1
Eoc - IosiBellinzonaSwitzerland1
Flinders Medical CentreBedford ParkAustralia6
HFR Hôpital FribourgeoisFribourgSwitzerland1
Inselspital BernBernSwitzerland22
Institut BergoniéBordeauxFrance47
Institut Jules Bordet - HUBAnderlechtBelgium1
Istituto Nazionale Tumori "Regina Elena"RomeItaly2
Istituto Oncologico VenetoPadovaItaly8
Kantonsspital BadenBadenSwitzerland11
Kantonsspital St.GallenSankt GallenSwitzerland5
Kantonsspital WinterthurWinterthurSwitzerland13
Le Mans - CHGLe MansFrance10
Lyon - Centre Léon BérardLyonFrance4
Maidstone and Tunbridge Wells NHS TrustMaidstoneUnited Kingdom4
Nepean HospitalPenrithAustralia1
NKIAmsterdamNetherlands1